Quratis
Category:
Venture
Main Business Area
Quratis is a company that focuses on the development of vaccines. They are developing a tuberculosis vaccine (QTP101) and a COVID-19 vaccine (QTP104). They also have a platform for Peptide Nucleic Acid (PNA), a synthetic analogue of DNA in which the deoxyribose phosphate backbone is replaced by a polyamide chain.
Find out more companies
Related products
-
VentureMedigen Human Care
T cell immunotherapies for solid tumors, vaccine safety and natural immunity
-
-
-
-
VentureAprogen
Their main modalities include SDR-Grafting, Recombinant Protein Fusion, CHIMPS Bispecific Antibodies, SHOCAP Bispecific Antibodies, and Bitargeting Receptor-Antibody Hybrid